Health
Modified SARS-CoV-2 receptor-binding domain could increase vaccine efficacy, says study – News-Medical.Net
A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, has spread to over 58.8 million worldwide and caused over 1.3 million deaths. The rush to develop safe and effective vaccines to prevent the ongoing spread of SARS-CoV-2 is nearing the finish line as several promising candidates await regulatory body approval for widescale distribution and use.
A team of researchers from the USA and China have engineered a…
-
Business13 hours agoWarning! These ASX 200 shares were just downgraded
-
Business11 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
Noosa News6 hours agoVegetables and herbs you can easily and cheaply grow from seeds
-
General22 hours agoTelco Exetel fined $694K after scammers bypass verification processes, access bank accounts